72 results on '"Beal JR"'
Search Results
2. Systematic notes on the genus Formicilla in the United States and Mexico (Coleoptera: Anthicidae)
- Author
-
Beal Jr., R. S. and BioStor
- Published
- 1950
3. The Origin of Likin, 1835–1864
- Author
-
Edwin George Beal, Jr and Edwin George Beal, Jr
- Abstract
During the Taiping Rebellion it was necessary for the Chinese government to find new sources of revenue to fund military provisions. This study provides a detailed history of the origin of the likin tax system, first introduced in 1853, a tax on goods and services in transit.
- Published
- 2020
4. Description of a new species of Caccoleptus (Coleoptera: Dermestidae) from Brazil
- Author
-
R. S. Beal Jr
- Subjects
Science (General) ,Q1-390 - Abstract
Abstract A new species of dermestid beetle, Caccoleptus honeymani, is described, the first known member of the genus from Brazil. Notes are given on another Brazilian species of the genus, which is not formally named at this time.
- Published
- 1979
- Full Text
- View/download PDF
5. A New California Species Of Egidyella Reitter (Coleoptera: Dermestidae), A Genus Previously Unknown In The New World
- Author
-
R. S. Beal, Jr. and Zhantiev, R. D.
- Subjects
Coleoptera ,Insecta ,Arthropoda ,Animalia ,Biodiversity ,Taxonomy ,Dermestidae - Abstract
R. S. Beal, Jr., Zhantiev, R. D. (2001): A New California Species Of Egidyella Reitter (Coleoptera: Dermestidae), A Genus Previously Unknown In The New World. The Coleopterists Bulletin 55 (1): 70-74, DOI: 10.1649/0010-065x(2001)055[0070:ancsoe]2.0.co;2
- Published
- 2001
6. Statins Use and Risk for Brain Metastasis From Lung Cancer
- Author
-
Leigh, D., primary, Eken, J., additional, Beal, JR, additional, Ganti, AK, additional, and Sahmoun, AE, additional
- Published
- 2010
- Full Text
- View/download PDF
7. Letters
- Author
-
Schnur, Barry, Davidson, Ezra K., Ciolkowski, David B., MacAuslan, Ian J., and Beal, Jr., Kenneth L.
- Abstract
To the Editor: This PC Week (Aug. 30) raises some interesting points which I feel inclined to reply to. 1) Technical parity between Borland, Lotus, and Microsoft. No major argument […]
- Published
- 1993
8. Statins Use and Risk for Brain Metastasis From Lung Cancer.
- Author
-
Leigh, D., Eken, J., Beal, JR, Ganti, AK, and Sahmoun, AE
- Subjects
BRAIN cancer risk factors ,LUNG cancer ,STATINS (Cardiovascular agents) ,EPIDEMIOLOGY ,HYDROPHOBIC surfaces ,COHORT analysis ,PROPORTIONAL hazards models - Abstract
Laboratory data suggest an association between statins and risk of brain metastasis (BM) in patients diagnosed with lung cancer. Our retrospective cohort included 252 patients diagnosed with lung cancer and 55 (22%) patients subsequently developed BM. The risk of BM was significantly higher in younger patients (p < .0007). The multivariable Cox model did not show a significant association between statin use and BM from lung cancer (Hazard-Ratio (HR) = 1.20, 95% confidence interval (CI): 0.68-2.13). Future studies should focus on late stage NSCLC and examine the incidence of BM among statin users at the time of death. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
9. Synthesis of New Fluorine Compounds
- Author
-
OZARK-MAHONING CO TULSA OK, Beal, Jr, James B, OZARK-MAHONING CO TULSA OK, and Beal, Jr, James B
- Abstract
Reactions were studied in which high pressure and elevated temperatures were employed. Pressures ranged from 340 to about 680 atm. The reactions studied were as follows: OF2 with CsClF4, OF2 with ClF3, OF2 with N2F4, CsF with NF3, fluorine with NF3, and CsF and fluorine with NF3., Sponsored in part by DARPA. See also Rept. no. AFRPL-TR-66-49, dated Mar 1966, AD0480450.
- Published
- 1966
10. Description of a new species of Caccoleptus (Coleoptera: Dermestidae) from Brazil
- Author
-
Beal Jr, R. S., primary
- Published
- 1979
- Full Text
- View/download PDF
11. The Origin of Likin, 1835–1864
- Author
-
Beal, Jr., Edwin George, primary
- Published
- 1958
- Full Text
- View/download PDF
12. The I.G. in Peking (Book Review).
- Author
-
Beal Jr., Edwin G.
- Subjects
CUSTOMS administration ,NONFICTION - Abstract
Reviews the book 'The I.G. in Peking: Letters of Robert Hart, Chinese Maritime Customs, 1868-1907,' edited by John Fairbank et al.
- Published
- 1977
- Full Text
- View/download PDF
13. Foreword
- Author
-
Beal, Jr., Edwin George
- Published
- 1958
14. II. The Failure of the Traditional System of Taxation to Meet Expanding Needs (1850-53)
- Author
-
Beal, Jr., Edwin George
- Published
- 1958
15. Index
- Author
-
Beal, Jr., Edwin George
- Published
- 1958
16. Selected Bibliography
- Author
-
Beal, Jr., Edwin George
- Published
- 1958
17. III. The First Collection of Likin
- Author
-
Beal, Jr., Edwin George
- Published
- 1958
18. Notes
- Author
-
Beal, Jr., Edwin George
- Published
- 1958
19. Author's Preface
- Author
-
Beal, Jr., Edwin George
- Published
- 1958
20. Part II Translations of Selected Chinese Texts
- Author
-
Beal, Jr., Edwin George
- Published
- 1958
21. IV. The Adoption of Likin
- Author
-
Beal, Jr., Edwin George
- Published
- 1958
22. V. The Early Operation of Likin
- Author
-
Beal, Jr., Edwin George
- Published
- 1958
23. I. Several Hypotheses Regarding Ch'ing Finance
- Author
-
Beal, Jr., Edwin George
- Published
- 1958
24. Contents
- Author
-
Beal, Jr., Edwin George
- Published
- 1958
25. Part I Analysis
- Author
-
Beal, Jr., Edwin George
- Published
- 1958
26. Title, Copyright
- Author
-
Beal, Jr., Edwin George
- Published
- 1958
27. WASTE HEAT USES CUT THERMAL POLLUTION.
- Author
-
Beal, Jr, S
- Published
- 1971
28. The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development.
- Author
-
Westphalen CB, Martins-Branco D, Beal JR, Cardone C, Coleman N, Schram AM, Halabi S, Michiels S, Yap C, André F, Bibeau F, Curigliano G, Garralda E, Kummar S, Kurzrock R, Limaye S, Loges S, Marabelle A, Marchió C, Mateo J, Rodon J, Spanic T, Pentheroudakis G, and Subbiah V
- Subjects
- Humans, Medical Oncology methods, Medical Oncology standards, Antineoplastic Agents therapeutic use, Europe, Biomarkers, Tumor genetics, Neoplasms drug therapy, Neoplasms pathology, Neoplasms classification, Drug Development methods, Precision Medicine methods, Precision Medicine standards, Molecular Targeted Therapy methods
- Abstract
Background: Advances in precision oncology led to approval of tumour-agnostic molecularly guided treatment options (MGTOs). The minimum requirements for claiming tumour-agnostic potential remain elusive., Methods: The European Society for Medical Oncology (ESMO) Precision Medicine Working Group (PMWG) coordinated a project to optimise tumour-agnostic drug development. International experts examined and summarised the publicly available data used for regulatory assessment of the tumour-agnostic indications approved by the US Food and Drug Administration and/or the European Medicines Agency as of December 2023. Different scenarios of minimum objective response rate (ORR), number of tumour types investigated, and number of evaluable patients per tumour type were assessed for developing a screening tool for tumour-agnostic potential. This tool was tested using the tumour-agnostic indications approved during the first half of 2024. A taxonomy for MGTOs and a framework for tumour-agnostic drug development were conceptualised., Results: Each tumour-agnostic indication had data establishing objective response in at least one out of five patients (ORR ≥ 20%) in two-thirds (≥4) of the investigated tumour types, with at least five evaluable patients in each tumour type. These minimum requirements were met by tested indications and may serve as a screening tool for tumour-agnostic potential, requiring further validation. We propose a conceptual taxonomy classifying MGTOs based on the therapeutic effect obtained by targeting a driver molecular aberration across tumours and its modulation by tumour-specific biology: tumour-agnostic, tumour-modulated, or tumour-restricted. The presence of biology-informed mechanistic rationale, early regulatory advice, and adequate trial design demonstrating signs of biology-driven tumour-agnostic activity, followed by confirmatory evidence, should be the principles for tumour-agnostic drug development., Conclusion: The ESMO Tumour-Agnostic Classifier (ETAC) focuses on the interplay of targeted driver molecular aberration and tumour-specific biology modulating the therapeutic effect of MGTOs. We propose minimum requirements to screen for tumour-agnostic potential (ETAC-S) as part of tumour-agnostic drug development. Definition of ETAC cut-offs is warranted., (Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
29. Prognostic value of programmed cell death ligand 1 (PD-L1) expression in patients with stage III non-small cell lung cancer under different treatment types: a retrospective study.
- Author
-
Castro NM, Moura F, Hada AL, Garcia D, Victor EDS, Schvartsman G, Carvalho L, Fernandes MLC, Martins RS, Silva EFD, Santos SSMBD, Taniwaki L, Taranto P, Pontes J, Beal JR, Dutra ACP, Oliveira Filho JB, Araujo SEA, and Usón Junior PLS
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Biomarkers, Tumor analysis, Biomarkers, Tumor metabolism, Immunohistochemistry, Kaplan-Meier Estimate, Prognosis, Retrospective Studies, B7-H1 Antigen analysis, B7-H1 Antigen metabolism, Carcinoma, Non-Small-Cell Lung diagnosis, Carcinoma, Non-Small-Cell Lung pathology, Carcinoma, Non-Small-Cell Lung therapy, Lung Neoplasms pathology, Lung Neoplasms therapy, Neoplasm Staging
- Abstract
Objective: Currently programmed cell death protein 1 (PD-1) inhibitors in combination with other therapies are being evaluated to determine their efficacy in cancer treatment. However, the effect of PD-ligand (L) 1 expression on disease outcomes in stage III (EC III) non-small cell lung cancer is not completely understood. Therefore, this study aimed to assess the influence of PD-L1 expression on the outcomes of EC III non-small cell lung cancer., Methods: This study was conducted on patients diagnosed with EC III non-small cell lung cancer who underwent treatment at a tertiary care hospital. PD-L1 expression was determined using immunohistochemical staining, all patients expressed PD-L1. Survival was estimated using the Kaplan-Meier method. Relationships between variables were assessed using Cox proportional regression models., Results: A total of 49 patients (median age=69 years) with EC III non-small cell lung cancer and PD-L1 expression were evaluated. More than half of the patients were men, and most were regular smokers. The patients were treated with neoadjuvant chemotherapy, surgery, or sequential or combined chemotherapy and radiotherapy. The median progression-free survival of the entire cohort was 14.2 months, and the median overall survival was 20 months. There was no significant association between PD-L1 expression and disease progression, clinical characteristics, or overall survival., Conclusions: PD-L1 expression was not correlated with EC III non-small cell lung cancer outcomes. Whether these findings differ from the association with immune checkpoint inhibitors remains to be addressed in future studies.
- Published
- 2024
- Full Text
- View/download PDF
30. Role of Endometrial Extracellular Vesicles in Mediating Cell-to-Cell Communication in the Uterus: A Review.
- Author
-
Beal JR, Ma Q, Bagchi IC, and Bagchi MK
- Subjects
- Pregnancy, Female, Humans, Endometrium metabolism, Cell Communication, Embryo Implantation physiology, Uterus metabolism, Extracellular Vesicles metabolism
- Abstract
There are several critical events that occur in the uterus during early pregnancy which are necessary for the establishment and maintenance of pregnancy. These events include blastocyst implantation, uterine decidualization, uterine neoangiogenesis, differentiation of trophoblast stem cells into different trophoblast cell lineages, and formation of a placenta. These processes involve several different cell types within the pregnant uterus. Communication between these cell types must be intricately coordinated for successful embryo implantation and the formation of a functional maternal-fetal interface in the placenta. Understanding how this intricate coordination transpires has been a focus of researchers in the field for many years. It has long been understood that maternal endometrial tissue plays a key role in intercellular signaling during early pregnancy, sending signals to nearby tissues in a paracrine manner. Recently, insights have been obtained into the mechanisms by which these signaling events occur. Notably, the endometrium has been shown to secrete extracellular vesicles (EVs) that contain crucial cargo (proteins, lipids, RNA, miRNA) that are taken up by recipient cells to initiate a response leading to the occurrence of critical events during implantation and placentation. In this review, we aim to summarize the role that endometrium-derived EVs play in mediating cell-to-cell communications within the pregnant uterus to orchestrate the events that must occur to establish and maintain pregnancy. We will also discuss how aberrant endometrial EV signaling may lead to pathophysiological conditions, such as endometriosis and infertility.
- Published
- 2023
- Full Text
- View/download PDF
31. Runx1 regulates critical factors that control uterine angiogenesis and trophoblast differentiation during placental development.
- Author
-
Kannan A, Beal JR, Neff AM, Bagchi MK, and Bagchi IC
- Abstract
During early pregnancy in humans and rodents, uterine stromal cells undergo a remarkable differentiation to form the decidua, a transient maternal tissue that supports the growing fetus. It is important to understand the key decidual pathways that orchestrate the proper development of the placenta, a key structure at the maternal-fetal interface. We discovered that ablation of expression of the transcription factor Runx1 in decidual stromal cells in a conditional Runx1 -null mouse model ( Runx1
d/d ) causes fetal lethality during placentation. Further phenotypic analysis revealed that uteri of pregnant Runx1d/d mice exhibited severely compromised decidual angiogenesis and a lack of trophoblast differentiation and migration, resulting in impaired spiral artery remodeling. Gene expression profiling using uteri from Runx1d/d and control mice revealed that Runx1 directly controls the decidual expression of the gap junction protein connexin 43 (also known as GJA1), which was previously shown to be essential for decidual angiogenesis. Our study also revealed that Runx1 controls the expression of insulin-like growth factor (IGF) 2 and IGF-binding protein 4 (IGFBP4) during early pregnancy. While Runx1 deficiency drastically reduced the production of IGF2 by the decidual cells, we observed concurrent elevated expression of the IGFBP4, which regulates the bioavailability of IGFs, thereby controlling trophoblast differentiation. We posit that dysregulated expression of GJA1, IGF2, and IGFBP4 in Runx1d/d decidua contributes to the observed defects in uterine angiogenesis, trophoblast differentiation, and vascular remodeling. This study therefore provides unique insights into key maternal pathways that control the early phases of maternal-fetal interactions within a critical window during placental development., (© The Author(s) 2023. Published by Oxford University Press on behalf of National Academy of Sciences.)- Published
- 2023
- Full Text
- View/download PDF
32. Association Between Race and Usage of Pain Medications in Children With Long Bone Fractures in US Emergency Departments, 2011-2019.
- Author
-
Pekas D, Telken W, Sahmoun AE, and Beal JR
- Subjects
- Child, Humans, Retrospective Studies, Pain etiology, Pain complications, Analgesics therapeutic use, Emergency Service, Hospital, Analgesics, Opioid therapeutic use, Fractures, Bone complications
- Abstract
Objectives: The purpose of this study was to determine the association between race and analgesic administration for children with long bone fracture (LBF) in US emergency departments. Previous studies have shown conflicting results regarding association between race and analgesic administration for pediatric LBFs., Methods: We conducted a retrospective analysis of pediatric emergency department visits for LBF using the 2011-2019 National Hospital Ambulatory Medical Care Survey-Emergency Department. We investigated the diagnostic workup and analgesic prescription rate among White, Black, and other pediatric emergency department visits for LBF., Results: Of the estimated 292 million pediatric visits to US emergency departments from 2011 to 2019, 3.1% were LBFs. Black children were less likely to be seen for a LBF than White or other children (1.8% vs 3.6% and 3.1%, P < 0.001). There was no association between race and subjective pain scale ( P = 0.998), triage severity ( P = 0.980), imaging (x-ray, P = 0.612; computed tomography scan, P = 0.291), or analgesic administration (opioids, P = 0.068; nonsteroidal antiinflammatory drugs/acetaminophen, P = 0.750). Trend analysis showed a significant decrease in opioid administration for pediatric LBF from 2011 to 2019 ( P < 0.001), with 33.0% receiving opioids., Conclusions: There was no association between race and analgesic administration, including opioids, or diagnostic workup in pediatric LBF. In addition, there was a significant downtrend in opioid administration for pediatric LBF from 2011 to 2019., Competing Interests: Disclosure: The authors declare no conflict of interest., (Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
33. Response to Abemaciclib and Immunotherapy Rechallenge with Nivolumab and Ipilimumab in a Heavily Pretreated TMB-H Metastatic Squamous Cell Lung Cancer with CDKN2A Mutation, PIK3CA Amplification and TPS 80%: A Case Report.
- Author
-
Dias E Silva D, Borba GB, Beal JR, Botrus G, Osawa A, Araújo SEA, Moura F, Guendelmann RAK, and Uson Junior PLS
- Subjects
- Humans, Male, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Class I Phosphatidylinositol 3-Kinases genetics, Cyclin-Dependent Kinase Inhibitor p16 genetics, Epithelial Cells, Immunotherapy, Ipilimumab therapeutic use, Mutation, Nivolumab therapeutic use, Carcinoma, Non-Small-Cell Lung genetics, Carcinoma, Squamous Cell drug therapy, Lung Neoplasms genetics
- Abstract
Inactivation of the cyclin-dependent kinase inhibitor 2A (CDKN2A) gene is considerably more frequent in squamous cell lung cancer (SqCLC) than in other subtypes of lung cancer and may be a promising target for this histology. Here, we present the course of diagnosis and treatment of a patient with advanced SqCLC, harboring not only CDKN2A mutation but also PIK3CA amplification, Tumor Mutational Burden-High (>10 mutations/megabase), and a Tumor Proportion Score of 80%. After disease progression on multiple lines of chemotherapy and immunotherapy, he responded favorably to treatment with the CDK4/6i Abemaciclib and later achieved a durable partial response to immunotherapy rechallenge with a combination of anti-PD-1 and anti-CTLA-4, nivolumab, and ipilimumab.
- Published
- 2023
- Full Text
- View/download PDF
34. Extracellular Vesicles Secreted by Mouse Decidual Cells Carry Critical Information for the Establishment of Pregnancy.
- Author
-
Ma Q, Beal JR, Song X, Bhurke A, Bagchi IC, and Bagchi MK
- Subjects
- Pregnancy, Female, Mice, Animals, Matrix Metalloproteinase 2 metabolism, Proteomics, Stromal Cells metabolism, Embryo Implantation genetics, Endometrium, Decidua metabolism, Extracellular Vesicles
- Abstract
The mouse decidua secretes many factors that act in a paracrine/autocrine manner to critically control uterine decidualization, neovascularization, and tissue remodeling that ensure proper establishment of pregnancy. The precise mechanisms that dictate intercellular communications among the uterine cells during early pregnancy remain unknown. We recently reported that conditional deletion of the gene encoding the hypoxia-inducible transcription factor 2 alpha (Hif2α) in mouse uterus led to infertility. Here, we report that HIF2α in mouse endometrial stromal cells (MESCs) acts via the cellular trafficking regulator RAB27b to control the secretion of extracellular vesicles (EVs) during decidualization. We also found that Hif2α-regulated pathways influence the biogenesis of EVs. Proteomic analysis of EVs secreted by decidualizing MESCs revealed that they harbor a wide variety of protein cargoes whose composition changed as the decidualization process progressed. The EVs enhanced the differentiation capacity of MESCs and the production of angiogenic factors by these cells. We also established that matrix metalloproteinase-2, a prominent EV cargo protein, modulates uterine remodeling during decidualization. Collectively, our results support the concept that EVs are central to the mechanisms by which the decidual cells communicate with each other and other cell types within the uterus to facilitate successful establishment of pregnancy., (© The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2022
- Full Text
- View/download PDF
35. Extracellular vesicles secreted by human uterine stromal cells regulate decidualization, angiogenesis, and trophoblast differentiation.
- Author
-
Ma Q, Beal JR, Bhurke A, Kannan A, Yu J, Taylor RN, Bagchi IC, and Bagchi MK
- Subjects
- Cell Differentiation, Endothelial Cells cytology, Endothelial Cells physiology, Female, Humans, Neovascularization, Physiologic, Pregnancy, Stromal Cells cytology, Stromal Cells physiology, Decidua cytology, Decidua physiology, Extracellular Vesicles physiology, Trophoblasts cytology, Trophoblasts physiology
- Abstract
In humans, the uterus undergoes a dramatic transformation to form an endometrial stroma-derived secretory tissue, termed decidua, during early pregnancy. The decidua secretes various factors that act in an autocrine/paracrine manner to promote stromal differentiation, facilitate maternal angiogenesis, and influence trophoblast differentiation and development, which are critical for the formation of a functional placenta. Here, we investigated the mechanisms by which decidual cells communicate with each other and with other cell types within the uterine milieu. We discovered that primary human endometrial stromal cells (HESCs) secrete extracellular vesicles (EVs) during decidualization and that this process is controlled by a conserved HIF2α-RAB27B pathway. Mass spectrometry revealed that the decidual EVs harbor a variety of protein cargo, including cell signaling molecules, growth modulators, metabolic regulators, and factors controlling endothelial cell expansion and remodeling. We tested the hypothesis that EVs secreted by the decidual cells mediate functional communications between various cell types within the uterus. We demonstrated that the internalization of EVs, specifically those carrying the glucose transporter 1 (GLUT1), promotes glucose uptake in recipient HESCs, supporting and advancing the decidualization program. Additionally, delivery of HESC-derived EVs into human endothelial cells stimulated their proliferation and led to enhanced vascular network formation. Strikingly, stromal EVs also promoted the differentiation of trophoblast stem cells into the extravillous trophoblast lineage. Collectively, these findings provide a deeper understanding of the pleiotropic roles played by EVs secreted by the decidual cells to ensure coordination of endometrial differentiation and angiogenesis with trophoblast function during the progressive phases of decidualization and placentation.
- Published
- 2022
- Full Text
- View/download PDF
36. Trends and risk factors in the antibiotic management of skin and soft tissue infections in the United States.
- Author
-
Storandt MH, Walden CD, Sahmoun AE, and Beal JR
- Subjects
- Anti-Bacterial Agents therapeutic use, Humans, Retrospective Studies, Risk Factors, Staphylococcus aureus, United States, Methicillin-Resistant Staphylococcus aureus, Soft Tissue Infections drug therapy, Staphylococcal Infections drug therapy, Staphylococcal Skin Infections drug therapy
- Abstract
Objective: The aim of this study was to examine the trends and risk factors of antibiotic treatment for skin and soft tissue infections (SSTIs), in the United States., Methods: We conducted a retrospective analysis of SSTIs visits utilizing the 2011-2016 National Ambulatory Medical Care Survey., Results: There were over 43 million visits for SSTIs in the US. We found no association between antibiotic treatment and gender, age, race, insurance, region, and metropolitan statistical area. Methicillin-resistant Staphylococcus aureus (MRSA) antibiotics were prescribed at 34.8% of SSTI visits, methicillin-sensitive Staphylococcus aureus (MSSA) antibiotics at 27.5%, and other antibiotics at 21.7%. Among visits treated with an antibiotic, 40.4% ( n = 378) received an antibiotic with MSSA coverage, while 59.6% ( n = 558) received an antibiotic with MRSA coverage. Region where the visit occurred was associated with the use of MSSA versus MRSA antibiotics ( p = .013). Mean age of visits receiving MSSA antibiotics was significantly older than visits receiving MRSA antibiotics, 53.8 ± 1.2 vs. 50.9 ± 0.9 ( p = .045)., Conclusions: This study found that providers more frequently utilize antibiotics with MRSA coverage for SSTIs. Antibiotic class chosen was associated with region, with MRSA coverage antibiotics more likely to be prescribed in the South. Additionally, individuals receiving antibiotics with MSSA coverage were older than those receiving antibiotics with MRSA coverage.
- Published
- 2022
- Full Text
- View/download PDF
37. Impact of tissue-agnostic approvals for patients with sarcoma.
- Author
-
Pestana RC, Beal JR, Parkes A, Hamerschlak N, and Subbiah V
- Subjects
- Biomarkers, Tumor genetics, Biomarkers, Tumor metabolism, Gene Fusion, Humans, Microsatellite Instability, Receptor Protein-Tyrosine Kinases genetics, Sarcoma diagnosis, Sarcoma drug therapy, Sarcoma genetics
- Abstract
Tissue-agnostic drug development is a major step forward in offering treatment options for rare tumors. Sarcomas are heterogeneous rare malignancies with more than 100 subtypes. Recent failure of Phase III trials, nonbiomarker-driven clinical trials, and rarity hamper developmental therapeutics in sarcomas. Since a 'one-size-fits-all' approach continues to be the standard of care, tissue-agnostic approvals assume significance in sarcomas. In this review, we focus on the clinical evidence of recent drug approvals for neurotrophic tyrosine receptor kinase (NTRK) fusion, microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) phenotype, and tumor mutation burden-high (TMB-H) status in the context of sarcomas, and the future landscape of tissue-agnostic targets, such as rearranged during transfection (RET), fibroblast growth factor receptor (FGFR), and neuregulin-1 (NRG1)., Competing Interests: Declaration of interests R.C.P. reports consulting fees from Bayer and honoraria from Pfizer, Merck, Bayer, and Servier outside the submitted work. V.S. reports grants from Eli Lilly/LOXO Oncology, Blueprint Medicines Corporation, Turning Point Therapeutics, Boston Pharmaceuticals; and grants from Helsinn Pharmaceuticals during the conduct of the study; in addition, V.S. reports a grant and advisory board/consultant position with Eli Lilly/Loxo Oncology during the conduct of the study; research grants from Roche/Genentech, Bayer, GlaxoSmithKline, Nanocarrier, Vegenics, Celgene, Northwest Biotherapeutics, Berghealth, Incyte, Fujifilm, D3, Pfizer, Multivir, Amgen, Abbvie, Alfa-sigma, Agensys, Boston Biomedical, Idera Pharma, Inhibrx, Exelixis, Blueprint Medicines, Altum, Dragonfly Therapeutics, Takeda, National Comprehensive Cancer Network, NCI-CTEP, University of Texas MD Anderson Cancer Center, Turning Point Therapeutics, Boston Pharmaceuticals, Novartis, Pharmamar, Medimmune; an advisory board/consultant position with Helsinn, Incyte, QED Pharma, Daiichi-Sankyo, Signant Health, Novartis, Janssen, Relay Therapeutics, Roche, Medimmune; travel funds from Pharmamar, Incyte, ASCO, ESMO; other support from Medscape; all outside the submitted work. No disclosures were reported by the other authors., (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
38. Antibiotic utilization for adult acute respiratory tract infections in United States Emergency Departments.
- Author
-
Schroeder AM, Lewis SS, Sahmoun AE, and Beal JR
- Subjects
- Adult, Antimicrobial Stewardship, Female, Health Surveys, Humans, Male, Respiratory Tract Infections epidemiology, Retrospective Studies, United States epidemiology, Anti-Bacterial Agents therapeutic use, Emergency Service, Hospital statistics & numerical data, Practice Patterns, Physicians' statistics & numerical data, Respiratory Tract Infections drug therapy
- Abstract
Background: Antibiotic stewardship programs have been a major focus in recent years to curtail antibiotic resistance. The purpose of this study was to evaluate antibiotic utilization for acute respiratory tract infections (ARTI) in the Emergency Department (ED) setting., Material and Methods: A retrospective analysis of adult ARTI visits to EDs utilizing 2011-2017 National Hospital Ambulatory Medical Care Survey- Emergency Department (NHAMCS-ED) datasets was conducted. Included were all visits of adults (≥18 years) diagnosed with ARTI. Antibiotics were determined based upon NHAMCS-ED use of the Multum Lexicon Drug Database coding system. All significance tests were two-sided, P-value <0.05 for significance., Results: A total of 4632 unweighted ED visits, which represented more than 28 million US ED visits from 2011 to 2017, with 57.2% receiving a prescription for antibiotics. Antibiotic prescriptions for ARTI significantly declined from 65.8% in 2011 to 54.3% in 2017 (P = 0.046). Among all visits, patients were more likely to receive an antibiotic if they were over age 45 (33.0% vs 27.6%, P = 0.005), male (36.7% vs. 32.3%, P = 0.039), and presenting in a non-MSA ED (21.4% vs. 14.5%, P = 0.002). No association was found between antibiotic prescription and race (P = 0.076) insurance (P = 0.488), CBC (P = 0.148), x-ray (P = 0.278), and blood cultures (P = 0.182)., Conclusion: We found a significant reduction in the utilization of antibiotics among adult ARTI visits to U.S. EDs from 2011 to 2017. This is an improvement from previous studies which showed no change, suggesting that antimicrobial stewardship efforts may be impacting overall antibiotic use and should continue to be practiced., Competing Interests: Declaration of Competing Interest The authors report no conflicts of interest., (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
39. The efficacy of low dose short-term prednisone therapy for remission induction in newly diagnosed rheumatoid arthritis patients.
- Author
-
Stacy JM, Greenmyer JR, Beal JR, Sahmoun AE, and Diri E
- Subjects
- Humans, Remission Induction, Retrospective Studies, Treatment Outcome, Arthritis, Rheumatoid diagnosis, Arthritis, Rheumatoid drug therapy, Glucocorticoids administration & dosage, Prednisone administration & dosage
- Abstract
Background: The ACR/EULAR recommendations endorse the use of glucocorticoids (GCs) for rheumatoid arthritis (RA) patients' flares and as a bridge to a DMARD. However, the recommendation of low dose short-term monotherapy with (GCs) remains open to the discretion of the clinician. The aim of this study was to assess whether a short-term use of low dose prednisone monotherapy was effective in inducing remission in newly diagnosed RA patients., Methods: A retrospective analysis of patients newly diagnosed with RA at a Community Health Center in North Dakota was performed based on the ACR/EULAR RA classification criteria. Demographic and clinical data were abstracted from patients' medical charts. Patients treated with (< 10 mg/day) of prednisone up to 6 months were included. Response to prednisone was analyzed according to pre- and post-treatment DAS28-ESR score and EULAR response criteria., Results: Data on 201 patients were analyzed. The mean prednisone dose was 8 mg/day (range: 5-10; SD = 1.2) and the mean treatment duration was 42.2 days (12-177; 16.9). Disease severity significantly improved from baseline to follow-up for: tender joint count (8.6 ± 4.8 vs. 1.5 ± 3.3; P < 0.001), swollen joint count (6.2 ± 5.0 vs. 1.4 ± 3.0; P < 0.001), and visual analog pain score (4.8 ± 2.6 vs. 2.1 ± 2.5; P < 0.001). DAS28-ESR disease severity significantly improved from baseline to follow-up: (5.1 ± 1.2 vs. 2.7 ± 1.3; P < 0.001). Per EULAR response criteria, 69.7% of patients showed good response to treatment and 20.4% showed moderate response. 54.2% of patients reached remission., Conclusion: Short-term use of low dose prednisone monotherapy induced disease remission and improved clinical severity of RA in the majority of newly diagnosed patients., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
40. A cross-sectional analysis of infant-driven and traditional feeding outcomes for neonatal intensive care unit infants.
- Author
-
Lane A, Pacella J, Beal JR, Sahmoun AE, Fedo-Rosvold S, Bellas WM, and Brower-Breitwieser C
- Subjects
- Breast Feeding, Cross-Sectional Studies, Female, Humans, Infant, Infant, Newborn, Patient Discharge, Infant, Premature, Intensive Care Units, Neonatal
- Abstract
Objective: The goal of this study was to assess the impact of infant-driven feeding (IDF) compared to traditional feeding protocols in promoting earlier successful feeding outcomes., Study Design: We performed a cross-sectional analysis of infants admitted to a level three neonatal intensive care unit (NICU) over a 2-year period. We compared infants fed with the traditional protocol to those under the IDF protocol., Results: Infants in the IDF group were younger at first feed (p < 0.001). There was no difference in age at nasogastric (NG) tube removal or at discharge, length of stay, or percentage breastfeeding at discharge. There were no differences in outcomes within two subgroups born at <35 and <32 weeks gestation, respectively., Conclusion: The IDF program led to earlier initiation of oral feeding. However, this did not lead to earlier NG tube removal or discharge, a shorter length of stay, or increase in the rates of breastfeeding., (© 2021. The Author(s), under exclusive licence to Springer Nature America, Inc.)
- Published
- 2021
- Full Text
- View/download PDF
41. Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain.
- Author
-
Tan TJC, Yuan M, Kuzelka K, Padron GC, Beal JR, Chen X, Wang Y, Rivera-Cardona J, Zhu X, Stadtmueller BM, Brooke CB, Wilson IA, and Wu NC
- Subjects
- Amino Acid Sequence, Angiotensin-Converting Enzyme 2 chemistry, Angiotensin-Converting Enzyme 2 metabolism, Antibodies, Neutralizing chemistry, Antibodies, Neutralizing metabolism, Antibody Formation, COVID-19 metabolism, COVID-19 virology, Complementarity Determining Regions chemistry, Complementarity Determining Regions immunology, Complementarity Determining Regions metabolism, Crystallography, X-Ray, High-Throughput Nucleotide Sequencing methods, Humans, Models, Molecular, Protein Binding, Protein Domains, SARS-CoV-2 isolation & purification, SARS-CoV-2 metabolism, Spike Glycoprotein, Coronavirus chemistry, Spike Glycoprotein, Coronavirus metabolism, Angiotensin-Converting Enzyme 2 immunology, Antibodies, Neutralizing immunology, COVID-19 immunology, SARS-CoV-2 immunology, Spike Glycoprotein, Coronavirus immunology
- Abstract
Since the COVID-19 pandemic onset, the antibody response to SARS-CoV-2 has been extensively characterized. Antibodies to the receptor binding domain (RBD) on the spike protein are frequently encoded by IGHV3-53/3-66 with a short complementarity-determining region (CDR) H3. Germline-encoded sequence motifs in heavy chain CDRs H1 and H2 have a major function, but whether any common motifs are present in CDR H3, which is often critical for binding specificity, is not clear. Here, we identify two public clonotypes of IGHV3-53/3-66 RBD antibodies with a 9-residue CDR H3 that pair with different light chains. Distinct sequence motifs on CDR H3 are present in the two public clonotypes that seem to be related to differential light chain pairing. Additionally, we show that Y58F is a common somatic hypermutation that results in increased binding affinity of IGHV3-53/3-66 RBD antibodies with a short CDR H3. These results advance understanding of the antibody response to SARS-CoV-2.
- Published
- 2021
- Full Text
- View/download PDF
42. Pseudoprogression with Neoadjuvant Immunotherapy for Cutaneous Melanoma.
- Author
-
Garcia D, Beal JR, Alvarez DM, Macarenco RSES, and Schvartsman G
- Abstract
Immune checkpoint inhibitors (ICI) have drastically changed the landscape of metastatic melanoma management, thus significantly improving survival. Clinically, assessing treatment response may be challenging in a portion of cases due to a massive influx of immune cells into the tumor microenvironment, causing a transient increase in the target lesion size. This phenomenon, coined pseudoprogression, can occur in 5-10% of metastatic patients, and it is commonly followed by a tumor regression. Its incidence, however, may be underestimated, given its ephemeral nature and often being documented in visceral metastatic lesions, which are only assessed by imaging scans every 2-3 months. More recently, ICI has been studied in the neoadjuvant setting, yielding durable pathological responses in patients with cutaneous melanoma. Here, we report a case of a large retroauricular melanoma mass with regional lymph node involvement treated with ipilimumab and nivolumab combination therapy that developed pseudoprogression. Initially documented as an increase in size along with inflammatory features, followed by a dramatic clinical improvement. A complete regression was pathologically documented after 3 months and the patient remains disease-free for 14 months after treatment initiation. In conclusion, we document a pseudoprogression case during neoadjuvant ICI treatment and raise the question of whether the incidence of this phenomenon is higher when observed in superficial lesions, which can be assessed by routine physical exam., Competing Interests: G.S. declares consulting services for Bristol-Myers Squibb, Merck, Sharp & Dome, AstraZeneca, Sanofi, Amgen, Roche, and Novartis., (Copyright © 2021 by S. Karger AG, Basel.)
- Published
- 2021
- Full Text
- View/download PDF
43. Sequence signatures of two IGHV3-53/3-66 public clonotypes to SARS-CoV-2 receptor binding domain.
- Author
-
Tan TJC, Yuan M, Kuzelka K, Padron GC, Beal JR, Chen X, Wang Y, Rivera-Cardona J, Zhu X, Stadtmueller BM, Brooke CB, Wilson IA, and Wu NC
- Abstract
Since the COVID-19 pandemic onset, the antibody response to SARS-CoV-2 has been extensively characterized. Antibodies to the receptor binding domain (RBD) on the spike protein are frequently encoded by IGHV3-53/3-66 with a short CDR H3. Germline-encoded sequence motifs in CDRs H1 and H2 play a major role, but whether any common motifs are present in CDR H3, which is often critical for binding specificity, have not been elucidated. Here, we identify two public clonotypes of IGHV3-53/3-66 RBD antibodies with a 9-residue CDR H3 that pair with different light chains. Distinct sequence motifs on CDR H3 are present in the two public clonotypes that appear to be related to differential light chain pairing. Additionally, we show that Y58F is a common somatic hypermutation that results in increased binding affinity of IGHV3-53/3-66 RBD antibodies with a short CDR H3. Overall, our results advance fundamental understanding of the antibody response to SARS-CoV-2.
- Published
- 2021
- Full Text
- View/download PDF
44. DAS28-CRP Cutoffs for High Disease Activity and Remission Are Lower Than DAS28-ESR in Rheumatoid Arthritis.
- Author
-
Greenmyer JR, Stacy JM, Sahmoun AE, Beal JR, and Diri E
- Abstract
Objective: Guidelines do not specify how cutoffs for high disease activity differ between the Disease Activity Score 28-joint count indices DAS28-erythrocyte sedimentation rate (ESR) and DAS28-C-reactive protein (CRP). Studies that compare DAS28-CRP and DAS28-ESR depend on data from clinical trials, registries, or practices with multiple providers. Existing studies use data from patients who received immunosuppressive therapy. This study compared the DAS28-ESR and DAS28-CRP values from immunosuppressive treatment-naïve patients in a single physician practice., Methods: A retrospective electronic medical chart review was conducted for new diagnoses of rheumatoid arthritis (RA; International Classification of Diseases [ICD]-9 714), based on the American College of Rheumatology/European League against Rheumatology 2010 RA classification criteria. The number of patients with high disease activity (>5.1) was compared using ESR and CRP data to calculate the proportion of discordance. A receiver operator curve and Youden index was used to calculate the DAS28-CRP high disease activity cutoff estimation that corresponds with DAS28-ESR of more than 5.1., Results: There were 171 patients included in this study. The baseline mean DAS28-ESR was higher than the baseline mean DAS-28 CRP: 5.1 ± 1.2 versus 4.1 ± 1.0 (P < 0.001); 48.5% of patients met criteria for high disease activity (score >5.1) compared with only 14.6% when measured by DAS28-CRP. Discordance was 33.9%. κ coefficient was only .307. Receiver operator curve and Youden index analysis suggested that the cutoff point for high disease activity of DAS28-CRP greater than 4.1, which corresponds to DAS28-ESR greater than 5.1. Similarly, DAS28-ESR posttreatment scores were significantly higher than DAS28-CRP. When measured by DAS28-ESR, patients in remission had higher scores as measured by DAS28-ESR (1.81) than DAS28-CRP (1.45)., Conclusion: There is a difference between DAS28-ESR and DAS28-CRP, even when calculated for immunosuppressive treatment-naïve patients. DAS28-CRP is significantly lower than DAS28-ESR., (© 2020 The Authors. ACR Open Rheumatology published by Wiley Periodicals LLC on behalf of American College of Rheumatology.)
- Published
- 2020
- Full Text
- View/download PDF
45. Differences in Clinical Management and Outcomes of American Indian and White Women Diagnosed With Endometriosis.
- Author
-
Spagnolia A, Beal JR, and Sahmoun AE
- Abstract
Objective: Endometriosis is a chronic, painful disease that can be disabling. There is a scarcity of research on the clinical management and outcomes of endometriosis in American Indian (AI) women. The aim of this study was to determine whether there are discrepancies between AI and White women in symptoms at presentation, initial diagnosis methods, clinical management, and long-term outcomes of endometriosis, in a rural state. Materials and methods: This retrospective study described and compared the clinical management and long-term outcomes of AI and White women diagnosed with endometriosis. All statistical tests were two-tailed with p-value < .05 considered to be significant. Results: 110 women diagnosed with endometriosis were included in the study, with 50% (n = 55) AI and 50% (n = 55) White. White women were more likely to have private insurance (80% vs. 42%; p < 0.001). AI women were more likely than White women to report abdominal pain at diagnosis (20.3% vs. 9%; p = 0.010), and be diagnosed with mild endometriosis symptoms at the initial visit, (44.4% vs. 10%; p = 0.051). White women were more likely to report a reduction or cessation of pain compared to AI women (63.3% vs. 34%; p = 0.004). Conclusion: We found the majority of women continue to report pain long after endometriosis diagnosis. AI women were less likely to report a reduction or cessation of pain. Future research should investigate why pain is more persistent in AI women., (Copyright © Tehran University of Medical Sciences.)
- Published
- 2020
- Full Text
- View/download PDF
46. The Association Between Patient Visit Demographics and Opioid Analgesic Received in the Emergency Department.
- Author
-
Richards LJ, Hopkins NJ, Colwell NA, Sahmoun AE, and Beal JR
- Abstract
Introduction: Minimal research has been conducted on the prescribing patterns of emergency room physicians. The opioid epidemic is a well-known public health crisis and increased knowledge of providers' tendencies to prescribe opioids over other analgesia may help to update guidelines, improve patient safety, and lower the amount of opioid diversion and death from overdose. The purpose of this study was to determine the association between patient visit demographics and prescribed opiate analgesics., Methods: We conducted a retrospective study analyzing adult patient visits that were seen in the emergency setting for acute pain including chest pain, back pain, abdominal pain, headache, face/tooth/ear, or musculoskeletal pain, utilizing the 2011-2016 National Hospital Ambulatory Medical Care Survey Emergency Department Patient Record dataset. We analyzed the relationship between various patient visit characteristics and whether opiate analgesics were given or prescribed. Results: Our study included 73,983 visits for pain, representing an estimated 407 million weighted visits over the study period. We found that those who received opiates were more likely to be female, 62.9% vs. 60.2% and more likely to be white, 74.2% vs. 71.3 %. Furthermore, visits that received opiates were more likely to be younger, have private insurance, and be in increased pain (all P-values = 0.000). Conclusion: We found that certain patient visit characteristics - including being female, white, younger, and private insurance - were given opiates more in the emergency department. Females have been found to report more pain, the elderly have special considerations regarding pain medications (including the risk of delirium and drug-drug interactions), while insurance status may be confounded by age (Medicare being a large portion of government insurance). However, explanations for differences in prescription rates by race could not be easily discerned., Competing Interests: The authors have declared that no competing interests exist., (Copyright © 2019, Richards et al.)
- Published
- 2019
- Full Text
- View/download PDF
47. Race and Length of Time Pursuing Pregnancy Among Women Who Utilized Medical Help to Get Pregnant.
- Author
-
Olig E, Mountan S, Beal JR, and Sahmoun AE
- Abstract
Objective: The evaluation of racial disparities in access to and use of infertility services in the U.S. has been documented. The aims of this study were to: 1) investigate racial differences in length of time women report attempting to become pregnant until seeking medical help; and 2) determine the predictors of seeking medical help to achieve pregnancy. Materials and methods: The National Survey of Family Growth 2011-2015 was used to analyze the duration women attempted to get pregnant among those who sought medical help. Results: 563 women reported seeking medical help to achieve pregnancy. The majority 422 (81%) were white. Multiple linear regression showed that age (β = .93; p = .00), having less than high school education (β = 14.64; p = .01), and higher body mass index (β = .59; p = .00) are significantly associated with an increased length of time for seeking medical help to get pregnant. Religions other than Catholic or Protestant (β = -8.63; p = .04) is significantly associated with a decreased length of time for seeking medical help to get pregnant. Race was not associated with a significant difference in the length of time attempting to become pregnant (β = -1.80; p = .44). Conclusion: Age, education attainment, religious affiliation, and body mass index are significantly associated with the length of time pursuing pregnancy. Once women have utilized medical resources, racial differences in the length of time pursuing pregnancy are not apparent., (Copyright © Vali-e-Asr Reproductive Health Research Center, Tehran University of Medical Sciences.)
- Published
- 2019
48. Perspectives on the Therapeutic Benefits of Arginine Supplementation in Cancer Treatment.
- Author
-
Beal FLR, Beal PR, Beal JR, Carvalho-Neves N, Franco OL, and Silva ON
- Subjects
- Animals, Humans, Neoplasms diagnosis, Neoplasms metabolism, Treatment Outcome, Antineoplastic Agents administration & dosage, Arginine administration & dosage, Dietary Supplements, Neoplasms drug therapy
- Abstract
Background: Arginine is considered a semi-essential amino acid in healthy adults and the elderly. This amino acid seems to improve the immune system, stimulate cell growth and differentiation, and increase endothelial permeability, among other effects. For those reasons, it has been theorized that arginine supplementation may be used as an adjuvant to conventional cancer therapy treatments., Objective: This review aims to evaluate the existing knowledge of the scientific community on arginine supplementation in order to improve the efficacy of current cancer treatment., Results: Despite the continued efforts of science to improve treatment strategies, cancer remains one of the greatest causes of death on the planet in adults and elderly people. Chemo and radiotherapy are still the most effective treatments but at the cost of significant side effects., Conclusion: Thus, new therapeutic perspectives have been studied in recent years, to be used in addition to traditional treatments or not, seeking to treat or even cure the various types of cancer with fewer side effects., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2019
- Full Text
- View/download PDF
49. Pre-eclampsia and risk of subsequent hypertension: in an American Indian population.
- Author
-
Best LG, Lunday L, Webster E, Falcon GR, and Beal JR
- Subjects
- Adolescent, Adult, Female, Follow-Up Studies, Humans, Middle Aged, North Dakota epidemiology, Pregnancy, Retrospective Studies, Young Adult, Hypertension epidemiology, Indians, North American statistics & numerical data, Pre-Eclampsia epidemiology
- Abstract
Background and Objectives: Pre-eclampsia (PE) shares a number of proposed pathophysiologic mechanisms related to those implicated in cardiovascular disease (CVD), such as endothelial dysfunction, inflammation, insulin resistance, and impaired renal regulation. PE has also been associated with subsequent hypertension, CVD, and related mortality in later life., Methods: At follow-up, the four most recent blood pressures, body mass index (BMI), and use of hypertensive medications were recorded from clinic visits of 130 PE cases and 289 normal pregnancies. Student's t test, Chi-square testing, multivariate linear, and logistic regression were used in analysis., Results: Follow-up measurements occurred a mean of 13.11 years post PE pregnancy. Multivariate linear regression showed a significant and independent association between current systolic blood pressure and previous history of PE (β = 4.47, p = 0.04), while adjusting for age, BMI, and blood pressure from 1 year prior to and up to the 20th week of gestation. A similarly adjusted multivariate logistic regression model found an odds ratio of 3.43, 95% CI 1.83-6.43, p = 0.001 for subsequent hypertension. Logistic regression analysis of the quartile with follow-up of less than 7.19 years also shows independent association of prior PE with subsequent hypertension., Discussion and Conclusions: PE appears to confer risk of subsequent hypertension on this cohort of American Indian women within as little as 8 years. This risk is independent of additional risk factors such as increased age, BMI, and blood pressure prior to 20 weeks of gestation. There is evidence of increased risk among those with more severe PE.
- Published
- 2017
- Full Text
- View/download PDF
50. Bladder exstrophy.
- Author
-
Mendes GG and Lusa JR
- Abstract
Bladder exstrophy is a rare congenital anomaly resulting from failure of fusion of the middle of the pelvis line tissues during embryogenesis. It is characterized by malformation of the lower abdominal wall involving the genitourinary tract and the musculoskeletal system. Its incidence is estimated at 1:30,000 to 1:50,000 live births, and it is 2 or 3 times more frequent in males. The child's age is important and the best results are obtained when treatment is performed shortly after birth.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.